# Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions

> **NCT07371182** · NA · RECRUITING · sponsor: **West China Second University Hospital** · enrollment: 62 (estimated)

## Conditions studied

- Langerhans Cell Histiocytosis (LCH)

## Interventions

- **DRUG:** Luvometinib

## Key facts

- **NCT ID:** NCT07371182
- **Lead sponsor:** West China Second University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-19
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07371182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07371182, "Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07371182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*